Serum glucuronoxylomannan may be more appropriate for the diagnosis and therapeutic monitoring of Trichosporon fungemia than serum β-d-glucan

International Journal of Infectious Diseases

Volumn 16, Issue 8, 2012, Pages

  Liao, Yong ^a   Hartmann, Thomas ^b   Ao, Jun hong ^a   Yang, Rong ya ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BETA GLUCAN; CROSS REACTING ANTIGEN; GLUCURONOXYLOMANNAN;

ANTIGEN DETECTION; CELL WALL; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; FUNGEMIA; HIGH RISK POPULATION; HUMAN; LETTER; NONHUMAN; PATIENT MONITORING; PREDICTIVE VALUE; TREATMENT RESPONSE; TRICHOSPORON ASAHII; TRICHOSPORON BEIGELII; TRICHOSPORONOSIS;

ANTIFUNGAL AGENTS; BETA-GLUCANS; FUNGEMIA; HUMANS; POLYSACCHARIDES; TRICHOSPORONOSIS;

EID: 84864386075     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.03.009     Document Type: Letter

References (10)

1. Nakase K., Suzuki K., Kyo T., Kohara T., Sugawara Y., Katayama N. Is elevation of the serum β-d-glucan level a paradoxical sign for Trichosporon fungemia in patients with hematologic disorders?. Int J Infect Dis 2012, 16:e2-e4.
2. Lamoth F., Cruciani M., Mengoli C., Castagnola E., Lortholary O., Richardson M., Marchetti O β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 2012, 54:633-643.
3. Racil Z., Kocmanova I., Lengerova M., Weinbergerova B., Buresova L., Toskova M., et al. Difficulties in using 1,3-β-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies-high frequency of false-positive results and their analysis. J Med Microbiol 2010, 59:1016-1022.
4. Vecchiarelli A, Monari C. Capsular material of Cryptococcus neoformans: virulence and much more. Mycopathologia 2012 Feb 8. [Epub ahead of print].
5. Odabasi Z., Paetznick V.L., Rodriguez J.R., Chen E., McGinnis M.R., Ostrosky-Zeichner L. Differences in β-glucan levels in culture supernatants of a variety of fungi. Med Mycol 2006, 44:267-272.
6. Yamamoto K., Makimura K., Sudo T., Shibuya K., Uchida K., Yamaguchi H. Experimental disseminated trichosporonosis in mice: tissue distribution and therapy with antifungal agents. J Med Vet Mycol 1997, 35:411-418.
7. Campbell C.K., Payne A.L., Teall A.J., Brownell A., Mackenzie D.W. Cryptococcal latex antigen test positive in patient with Trichosporon beigelii infection. Lancet 1985, 2:43-44.
8. Lyman C.A., Devi S.J., Nathanson J., Frasch C.E., Pizzo P.A., Walsh T.J. Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity. J Clin Microbiol 1995, 33:126-130.
9. Karashima R., Yamakami Y., Yamagata E., Tokimatsu I., Hiramatsu K., Nasu M. Increased release of glucuronoxylomannan antigen and induced phenotypic changes in Trichosporon asahii by repeated passage in mice. J Med Microbiol 2002, 51:423-432.
10. Fonseca F.L., Frases S., Casadevall A., Fischman-Gompertz O., Nimrichter L., Rodrigues M.L. Structural and functional properties of the Trichosporon asahii glucuronoxylomannan. Fungal Genet Biol 2009, 46:496-505.